Wave Life Sciences Ltd Cash Flow-to-Debt Ratio
Wave Life Sciences Ltd cash flow-to-debt ratio. Wave Life Sciences Ltd (WVE) has a Cash Flow-to-Debt Ratio of -0.83x as of March 2026, meaning its operating cash flow of $-59.55 Million could theoretically repay -1% of its total liabilities ($71.81 Million) in one year. Check WVE cash flow quality index to evaluate the quality of earnings relative to operating cash generation.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of Wave Life Sciences Ltd (2013–2025)
Cash flow-to-debt ratio of Wave Life Sciences Ltd from 2013 to 2025. Historical debt coverage capacity for Wave Life Sciences Ltd across 13 annual periods. Check total reinvestment intensity of Wave Life Sciences Ltd to assess the company's total reinvestment commitment from operating cash flow.
Wave Life Sciences Ltd Cash Flow-to-Debt Ratio by Year (2013–2025)
Wave Life Sciences Ltd cash flow-to-debt ratio by year from 2013 to 2025. Year-by-year debt coverage analysis for Wave Life Sciences Ltd. For the full cash flow conversion analysis, see cash efficiency ratio of Wave Life Sciences Ltd.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -1.67x | $-187.49 Million | $112.27 Million | ▼ -57.8% |
| 2024 | -1.06x | $-151.03 Million | $142.69 Million | ▼ -1181.8% |
| 2023 | -0.08x | $-19.43 Million | $235.32 Million | ▲ +87.6% |
| 2022 | -0.67x | $-127.78 Million | $191.48 Million | ▼ -30.9% |
| 2021 | -0.51x | $-88.99 Million | $174.51 Million | ▲ +17.1% |
| 2020 | -0.62x | $-115.98 Million | $188.59 Million | ▲ +30.5% |
| 2019 | -0.89x | $-188.23 Million | $212.64 Million | ▼ -761.9% |
| 2018 | -0.10x | $-22.86 Million | $222.59 Million | ▲ +94.8% |
| 2017 | -1.99x | $-83.67 Million | $42.03 Million | ▼ -87.1% |
| 2016 | -1.06x | $-31.87 Million | $29.95 Million | ▼ -1.4% |
| 2015 | -1.05x | $-12.53 Million | $11.93 Million | ▲ +78.4% |
| 2014 | -4.86x | $-4.43 Million | $911.00K | ▼ -1279.8% |
| 2013 | -0.35x | $-3.55 Million | $10.09 Million | — |